The US Food and Drug Administration has approved a second gene therapy, this one from Kite Pharmaceuticals, the New York Times reports. The agency approved Novartis' Kymriah earlier this year.
The US Food and Drug Administration has approved a second gene therapy, this one from Kite Pharmaceuticals, the New York Times reports. The agency approved Novartis' Kymriah earlier this year.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.